282x Filetype PDF File size 0.29 MB Source: www.idexx.com
Diagnosing, Staging,
and Treating Chronic Kidney
Disease in Dogs and Cats
Chronic kidney disease (CKD) is diagnosed based
on evaluation of all available clinical and diagnostic
information in a stable patient. Following diagnosis
of CKD, the IRIS Board recommends using serum
creatinine or SDMA (ideally both) to stage CKD with
substaging based on assessment of arterial blood
pressure and proteinuria.
Step 1: Diagnose CKD
Clinical signs and physical Clinical presentation Physical examination findings
examination findings worsen Consider age, sex, breed predispositions, and relevant Can be normal in early stage CKD. Findings
with increasing severity of historical information, including medication history, may include palpable kidney abnormalities,
toxin/toxicant exposure, and diet. evidence of weight loss, dehydration,
kidney disease Can be subclinical in early stage CKD. Signs may include pale mucous membranes, uremic ulcers,
polyuria, polydipsia, weight loss, decreased appetite, evidence of hypertension, i.e., retinal
lethargy, dehydration, vomiting, and bad breath. hemorrhages/detachment.
To diagnose Stage 1 and early Stage 2 CKD OR To diagnose more advanced CKD (late Stage 2–4)
One or more of these diagnostic findings: Both of these diagnostic findings:
1 Creatinine SDMA Increased creatinine and SDMA concentrations 1
Creatinine SDMA Creatinine
increasing within the increasing within the
reference intervalreference interval where no reference intervalreference interval where no SDMA
prerenal cause is apparent prerenal cause is apparent
Jun ’11 Jun ’12 Jun ’13 June July Aug Sept Results of both tests should be interpreted
in light of patient’s hydration status.
Persistent increased SDMA* >14 µg/dL
2 plus
3 Abnormal kidney imaging
Urine Urine
specific gravity specific gravity 2
†
<1.030 <1.035
4 Persistent renal proteinuria
UPC >0.5 in dogs; UPC >0.4 in cats
0.6 0.7 1.0 1.030 Canine 1.008
Sept ’15 Oct ’15 Nov ’15
Urine protein to creatinine (UPC) ratio 1.035 Feline 1.008
†
See www.iris-kidney.com for more detailed staging, Note that some cats can produce hypersthenuric
therapeutic, and management guidelines. urine in the face of renal azotemia.
Step 2: Stage CKD
Stage 1 Stage 2 Stage 3 Stage 4
No azotemia Mild azotemia Moderate azotemia Severe azotemia
(Normal creatinine) (Normal or mildly
elevated creatinine)
Creatinine in mg/dL Less than 1.4–2.8 2.9–5.0 Greater than
1.4 µ µ 5.0
Stage Canine (125 µmol/L) (125–250 mol/L) (251–440 mol/L) (440 µmol/L)
based on
stable creatinine Less than 1.6–2.8 2.9–5.0 Greater than
Feline 1.6 µ µ 5.0
(140 µmol/L) (140–250 mol/L) (251–440 mol/L) (440 µmol/L)
SDMA* in µg/dL Less than 18–35 36–54 Greater than
Stage Canine 18 54
based on Less than Greater than
stable SDMA Feline 18 18–25 26–38 38
UPC ratio
Substage Canine Nonproteinuric <0.2 Borderline proteinuric 0.2–0.5 Proteinuric >0.5
based on Feline Nonproteinuric <0.2 Borderline proteinuric 0.2–0.4 Proteinuric >0.4
proteinuria
Systolic blood
pressure in mm Hg Normotensive <140 Prehypertensive 140–159
Substage based on _
Hypertensive 160–179 Severely hypertensive >180
blood pressure
Note: In the case of staging discrepancy between creatinine ®
*SDMA = IDEXX SDMA Test See www.iris-kidney.com for more
and SDMA, consider patient muscle mass and retesting detailed staging, therapeutic, and
both in 2–4 weeks. If values are persistently discordant, management guidelines.
consider assigning the patient to the higher stage.
Step 3: Treat CKD
Stage 1 Stage 2 Stage 3 Stage 4
Treatment Use nephrotoxic drugs Same as Stage 1 Same as Stage 2 Same as Stage 3
recommendations with caution Renal therapeutic diet Keep phosphorus Keep phosphorus
Correct prerenal and Treat hypokalemia in cats <5.0 mg/dL <6.0 mg/dL
postrenal abnormalities (<1.6 mmol/L) (<1.9 mmol/L)
Fresh water available at Treat metabolic acidosis Consider feeding tube for
all times Consider treatment nutritional and hydration
Monitor trends in creatinine of anemia support and ease of
and SDMA to document medicating
stability or progression Treat vomiting,
inappetence, and nausea
Investigate for and treat Increased enteral or
underlying disease and/or subcutaneous fluids may
complications be required to maintain
Treat hypertension if systolic hydration
blood pressure persistently Consider calcitriol therapy
>160 or evidence of in dogs
end-organ damage
Treat persistent proteinuria
with renal therapeutic diet
and medication
(UPC >0.5 in dogs;
UPC >0.4 in cats)
Keep phosphorus
<4.6 mg/dL (<1.5 mmol/L)
If required, use renal
therapeutic diet
plus phosphate binder
See www.iris-kidney.com for more detailed staging, therapeutic, and management guidelines.
no reviews yet
Please Login to review.